Shots:

• Royal Philips collaborated with BioIntelliSense- to integrate its BioSticker medical device into Philips’ RPM offering to help monitor at-risk patients from the hospital into the home
• Addition of multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms- including COVID-19
• The BioSticker is a single-use- FDA-cleared 510k class II wearable medical device that enables at-home passive monitoring with minute level data across a broad set of vital signs- physiological biometrics and symptomatic events (skin temperature- resting heart rate- resting respiratory rate- body position- activity levels- cough frequency) on a single device 30days

Click here to read full press release/ article | Ref: Philips | Image: Philips